Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
624,185
-
Share change
-
+10,698
-
Total reported value
-
$1,899,000
-
Put/Call ratio
-
0%
-
Price per share
-
$3.04
-
Number of holders
-
29
-
Value change
-
-$91,414
-
Number of buys
-
11
-
Number of sells
-
12
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2020
As of 31 Mar 2020,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
624,185 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, Frontier Wealth Management LLC, BlackRock Inc., ICM ASSET MANAGEMENT INC/WA, BOOTHBAY FUND MANAGEMENT, LLC, MORGAN JESS S & CO INC, PNC Financial Services Group, Inc., GEODE CAPITAL MANAGEMENT, LLC, and Rossmore Private Capital.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.